Mechanistically, both conditions converge on shared pathways such as chronic inflammation, hyperinsulinemia, immune suppression, and activation of pro-metastatic signaling cascades including PI3K/Akt/mTOR [65–67]. The gene discussed is MTOR; the disease is hyperinsulinism.